2021
DOI: 10.33483/jfpau.870815
|View full text |Cite
|
Sign up to set email alerts
|

Investigations on Antimicrobial and Antitubercular Activity of Some 4,5-Dihydro-1h-Pyrazole and Chalcone Derivatives

Abstract: Amaç: Bu çalışmada öncelikle şalkonlar ve bu şalkon türevlerinin hidrazitler ile reaksiyonu sonucu halka kapanması ile oluşan 4,5-dihidro-1H-pirazol yapısındaki bileşikler sentez edilmiş ve sentezlenen tüm bileşiklerin antimikrobiyal ve antitüberküler etkileri araştırılmıştır.Gereç ve Yöntem: Benzaldehit ve asetofenon türevlerinin alkali ortamda metanol içindeki reaksiyonuyla elde edilen şalkonların, hidrazit türevleri ile etanol içindeki reaksiyonu sonucu 4,5-dihidro-1H-pirazol türevleri elde edilmiştir. Sent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Unlike the concurrent administration of two medications, molecular hybridization offers pharmacokinetic benefits over single ligands. [4][5][6] The molecular hybrids comprising the pyrazole-furan backbone have exhibited diverse pharmacological properties such as antibacterial, [7][8][9] anti-Alzheimer,, [10,11] anticancer, [12][13][14][15] antiinflammatory (Cox-1 and Cox-2), [16] and anti-Parkinson's disease (α-synuclein aggregation inhibitor), [17] (Figure 1). Hence, proves to be a useful scaffold in drug design and discovery.…”
Section: Introductionmentioning
confidence: 99%
“…Unlike the concurrent administration of two medications, molecular hybridization offers pharmacokinetic benefits over single ligands. [4][5][6] The molecular hybrids comprising the pyrazole-furan backbone have exhibited diverse pharmacological properties such as antibacterial, [7][8][9] anti-Alzheimer,, [10,11] anticancer, [12][13][14][15] antiinflammatory (Cox-1 and Cox-2), [16] and anti-Parkinson's disease (α-synuclein aggregation inhibitor), [17] (Figure 1). Hence, proves to be a useful scaffold in drug design and discovery.…”
Section: Introductionmentioning
confidence: 99%